NeoGenomics, Inc. (NEO): $54.34

1.35 (+2.55%)

POWR Rating

Component Grades













Neogenomics Inc (NEO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NEO.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
11 $70 $46 $57.27 $52.99 8.08%

The Trend in the Analyst Price Target

Over the past 122 days, NEO's average price target has gone up $10.44.

NEO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 6 6 0 0 0 12

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NEO as an investment opportunity.

  • Neogenomics Inc's number of analysts covering the stock is higher than 75.71% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of NEO is higher than 22.43% of Healthcare stocks.
  • NEO has a greater average analyst price target than 75.64% of Healthcare stocks.
  • The variance in analysts' estimates of NEO is less than 34.62% of all US stocks.
  • NEO has a higher NA than just about none of of all US stocks.

Stocks similar to Neogenomics Inc in the Business Services industry regarding analyst recommendations and price targets are HCAT, TENB and SPT.

Make investment decisions regarding NEO using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6507 seconds.